Andrea Marchetti
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 22
-
- Renal cell carcinoma treatment 19
- Prostate Cancer Treatment and Research 10
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 7
- Hepatology top 10%
-
- Bladder and Urothelial Cancer Treatments 13
- Urinary and Genital Oncology Studies 6
-
- Renal and related cancers 9
-
- Radiopharmaceutical Chemistry and Applications 5
- Co-authors
- Francesco MassariMatteo RoselliniVeronica MollicaAlessandro RizzoMatteo SantoniElisa TassinariNicola BattelliLuca Faloppi
- Journals
- International Journal of Molecular Sciences (2 papers)European Urology (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Andrea Marchetti
45 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 564
- Pulmonary and Respiratory Medicine 629
- Cancer Research 276
- Hepatology 58
- Immunology 123
Countries citing papers authored by Andrea Marchetti
This map shows the geographic impact of Andrea Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Marchetti more than expected).
Fields of papers citing papers by Andrea Marchetti
This network shows the impact of papers produced by Andrea Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Marchetti. The network helps show where Andrea Marchetti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Marchetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 6 | |
| 6 | The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 studybreakdown → | 2023 | 115 |
| 7 | Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 studybreakdown → | 2023 | 107 |
| 8 | Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysisbreakdown → | 2023 | 117 |
| 9 | 2022 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 9 | |
| 12 | Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinomabreakdown → | 2022 | 138 |
| 13 | 2022 | 3 | |
| 14 | 2021 | 18 | |
| 15 | 2021 | 37 | |
| 16 | 2021 | 20 | |
| 17 | 2021 | 11 | |
| 18 | 2021 | 68 | |
| 19 | 2021 | 71 | |
| 20 | 2021 | 72 |
About Andrea Marchetti
Andrea Marchetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Renal cell carcinoma treatment (19 papers), Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Treatment and Research (10 papers), Renal and related cancers (9 papers), Cancer Genomics and Diagnostics (7 papers), Urinary and Genital Oncology Studies (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). The work is most often cited by research in Oncology (564 citations), Pulmonary and Respiratory Medicine (629 citations) and Cancer Research (276 citations). Andrea Marchetti has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Francesco Massari, Matteo Rosellini, Veronica Mollica, Alessandro Rizzo, Matteo Santoni, Elisa Tassinari, Nicola Battelli, Luca Faloppi, Valentina Tateo and Andrea Ardizzoni. Their work appears in journals such as International Journal of Molecular Sciences, European Urology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.